IRIS Accounts Production v24.3.0.553 09085793 director 1.4.23 31.3.24 31.3.24 true false true false false true false Fair value model Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh090857932023-03-31090857932024-03-31090857932023-04-012024-03-31090857932022-03-31090857932022-04-012023-03-31090857932023-03-3109085793ns15:EnglandWales2023-04-012024-03-3109085793ns14:PoundSterling2023-04-012024-03-3109085793ns10:Director12023-04-012024-03-3109085793ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3109085793ns10:SmallEntities2023-04-012024-03-3109085793ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3109085793ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3109085793ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3109085793ns10:FullAccounts2023-04-012024-03-3109085793ns10:OrdinaryShareClass12023-04-012024-03-3109085793ns10:Director22023-04-012024-03-3109085793ns10:RegisteredOffice2023-04-012024-03-3109085793ns5:CurrentFinancialInstruments2024-03-3109085793ns5:CurrentFinancialInstruments2023-03-3109085793ns5:ShareCapital2024-03-3109085793ns5:ShareCapital2023-03-3109085793ns5:SharePremium2024-03-3109085793ns5:SharePremium2023-03-3109085793ns5:RetainedEarningsAccumulatedLosses2024-03-3109085793ns5:RetainedEarningsAccumulatedLosses2023-03-3109085793ns5:PlantMachinery2023-04-012024-03-3109085793ns5:PlantMachinery2023-03-3109085793ns5:PlantMachinery2024-03-3109085793ns5:PlantMachinery2023-03-3109085793ns5:CostValuation2023-03-3109085793ns5:Subsidiary12023-04-012024-03-3109085793ns5:Subsidiary112023-04-012024-03-3109085793ns5:Subsidiary12024-03-3109085793ns5:Subsidiary12023-03-3109085793ns5:Subsidiary12022-04-012023-03-3109085793ns5:Subsidiary22023-04-012024-03-31090857933ns5:Subsidiary22023-04-012024-03-3109085793ns5:Subsidiary22024-03-3109085793ns5:Subsidiary22023-03-3109085793ns5:Subsidiary22022-04-012023-03-3109085793ns5:Subsidiary32023-04-012024-03-3109085793ns5:Subsidiary352023-04-012024-03-3109085793ns5:Subsidiary32024-03-3109085793ns5:Subsidiary32023-03-3109085793ns5:Subsidiary32022-04-012023-03-3109085793ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3109085793ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3109085793ns10:OrdinaryShareClass12024-03-31
















Unaudited Financial Statements for the Year Ended 31 March 2024

for

Multimedix Holdings Limited

Multimedix Holdings Limited (Registered number: 09085793)






Contents of the Financial Statements
for the Year Ended 31 March 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Multimedix Holdings Limited

Company Information
for the Year Ended 31 March 2024







DIRECTOR: Mrs M A Stevenson





REGISTERED OFFICE: Unit 56, Hayhill Industrial Estate
47 Hayhill
Barrow Upon Soar
Leicester
Leicestershire
LE12 8LD





REGISTERED NUMBER: 09085793 (England and Wales)





ACCOUNTANTS: Peter Upton
Bridge House
2 Bridge Avenue
Maidenhead
Berkshire
SL6 1RR

Multimedix Holdings Limited (Registered number: 09085793)

Balance Sheet
31 March 2024

31.3.24 31.3.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 15,109 22,730
Investments 5 735,000 735,000
Investment property 6 1,048,924 633,828
1,799,033 1,391,558

CURRENT ASSETS
Debtors 7 347,934 448,029
Cash at bank 10,216 15,390
358,150 463,419
CREDITORS
Amounts falling due within one year 8 990,105 559,027
NET CURRENT LIABILITIES (631,955 ) (95,608 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,167,078

1,295,950

CAPITAL AND RESERVES
Called up share capital 9 100 100
Share premium 1,249,902 1,249,902
Retained earnings (82,924 ) 45,948
SHAREHOLDERS' FUNDS 1,167,078 1,295,950

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 21 October 2024 and were signed by:





S C Hodgson - Director


Multimedix Holdings Limited (Registered number: 09085793)

Notes to the Financial Statements
for the Year Ended 31 March 2024

1. STATUTORY INFORMATION

Multimedix Holdings Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on cost

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Financial instruments
Basic financial instruments are recognised at settlement value.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

Multimedix Holdings Limited (Registered number: 09085793)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2023
and 31 March 2024 32,415
DEPRECIATION
At 1 April 2023 9,685
Charge for year 7,621
At 31 March 2024 17,306
NET BOOK VALUE
At 31 March 2024 15,109
At 31 March 2023 22,730

5. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 April 2023
and 31 March 2024 735,000
NET BOOK VALUE
At 31 March 2024 735,000
At 31 March 2023 735,000

The company's investments at the Balance Sheet date in the share capital of companies include the following:

Modality Limited
Registered office: Unit 56, Hayhill Industrial Estate, 47 Hayhill, Barrow Upon Soar, Leicestershire, England, LE12 8LD
Nature of business: The provider of medical equipment and repairs
%
Class of shares: holding
Ordinary 100.00
31.3.24 31.3.23
£    £   
Aggregate capital and reserves 180,617 762,649
Profit for the year 231,390 937,232

Multimedix Holdings Limited (Registered number: 09085793)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

5. FIXED ASSET INVESTMENTS - continued

Multi-Medix Limited
Registered office: Pera Business Park, Nottingham Road, Melton Mowbray, England, LE13 0PB
Nature of business: The provider of medical equipment and repairs
%
Class of shares: holding
Ordinary 100.00
31.3.24 31.3.23
£    £   
Aggregate capital and reserves (10,670 ) 26,977
(Loss)/profit for the year (37,647 ) 29,416

Consolidated accounts have not been prepared because the director believes that they would serve no useful purpose.

Elemtex Limited
Registered office: The Quarry, Plymouth Road, Tavistock, England, PL19 8AB
Nature of business: The provider of medical equipment and repairs
%
Class of shares: holding
ordinary 90.00
31.3.24 31.3.23
£    £   
Aggregate capital and reserves (12,759 ) (12,759 )
Profit for the year 33,786 33,786

6. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 April 2023 633,828
Additions 415,096
At 31 March 2024 1,048,924
NET BOOK VALUE
At 31 March 2024 1,048,924
At 31 March 2023 633,828

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Amounts owed by group undertakings 347,934 351,800
Other debtors - 77,500
Prepayments and accrued income - 18,729
347,934 448,029

Multimedix Holdings Limited (Registered number: 09085793)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Tax - 4,191
Social security and other taxes 4,343 3,351
Pension 226 -
Other creditors 40,447 447
Share holder loan 943,689 549,638
Accrued expenses 1,400 1,400
990,105 559,027

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.24 31.3.23
value: £    £   
100 Ordinary £1 100 100

10. RELATED PARTY DISCLOSURES

Modality Limited

A company under the control of Multimedix Holdings Limited


31.3.24 31.3.23
£ £
Amounts due from the related party at the balance sheet date 176,954 171,800



Elemtex Limited

A company under the control of Multimedix Holdings Limited

31.3.24 31.3.23
£ £
Amounts due from the related party at the balance sheet date 139,050 135,000


Multi-Medix Limited

A company under the control of Multimedix Holdings Limited

31.3.24 31.3.23
£ £
Amounts due from the related party at the balance sheet date 31,930 45,000

11. ULTIMATE CONTROLLING PARTY

The controlling party is S C Hodgson by virtue of his shareholding in the company.